
Moroidin
Description
Natural Occurrence and Research Significance of Moroidin-Type Peptides
This compound is primarily found in the stinging tree Dendrocnide moroides, a member of the nettle family (Urticaceae), native to the rainforests of East Australia. It has also been isolated from the seeds of Celosia argentea, an ornamental plant in the amaranth family (Amaranthaceae). google.com this compound is recognized as one of the bioactive compounds contributing to the excruciating sting of D. moroides. wikipedia.org
The research significance of this compound-type peptides lies in their distinct structural characteristics and their demonstrated biological activities. These peptides belong to a class of ribosomally synthesized and posttranslationally modified peptides (RiPPs) in plants. acs.orgnih.gov Their complex bicyclic structure, formed by unusual cross-linkages, makes them interesting targets for structural and synthetic studies. Furthermore, their observed inhibitory activity against tubulin polymerization has positioned them as lead structures in the search for new therapeutic agents, particularly in the field of cancer research. google.comumich.edu The low yields obtained from natural extraction and the challenges associated with their complex organic synthesis have driven research towards alternative production methods, such as biosynthesis in heterologous plant systems, highlighting their research importance. google.comacs.orgnih.gov
Overview of this compound as a Biologically Active Bicyclic Octapeptide
This compound is characterized as a bicyclic octapeptide. google.comwikipedia.org Its structure includes an N-terminal pyroglutamate and two macrocyclic linkages formed by side-chain cross-links. google.com Specifically, these linkages involve a C-C bond between the C6 of a tryptophan indole residue at the fifth position and a β-carbon of a leucine residue at the second position, and a C-N bond between the C2 of the same tryptophan indole and the N1 of a C-terminal histidine imidazole. google.com This unique bicyclic motif is a defining feature of this compound and related celogentins. google.comwikipedia.org
The biological activity of this compound includes its role as a pain-causing agent, particularly associated with the sting of D. moroides. google.comwikipedia.org More significantly from a therapeutic research perspective, this compound and its analogs, such as celogentin C, exhibit potent inhibitory activity against tubulin polymerization in vitro. google.comumich.edu Tubulin is a key protein involved in the formation of microtubules, which are essential components of the cytoskeleton and play a critical role in cell division. wikipedia.orgmit.edu By inhibiting tubulin polymerization, this compound disrupts microtubule formation, leading to cell cycle arrest and apoptosis in cancer cells. nih.gov This mechanism of action is similar to that of established chemotherapeutic agents like vincristine and paclitaxel, which are also plant-derived compounds that bind to tubulin. mit.edu Research has also explored this compound's effects on pathways involved in epithelial-mesenchymal transition (EMT) and vasculogenic mimicry in glioblastoma cells. researchgate.netnih.gov
The following table summarizes some key characteristics of this compound:
Characteristic | Detail | Source Plants | Biological Activity Highlights |
Structure | Bicyclic Octapeptide | Dendrocnide moroides, Celosia argentea | Tubulin polymerization inhibition, Pain-causing. google.comwikipedia.org |
Key Structural Features | N-terminal pyroglutamate, C-C (Leu-Trp) and C-N (Trp-His) side-chain macrocyclic linkages. google.com | ||
Molecular Target | Tubulin wikipedia.orgmit.edu |
Historical Context of Academic Research on this compound and Related Cyclopeptides
The investigation into the bioactive compounds of Dendrocnide moroides dates back several decades, driven by the plant's potent stinging properties. Early studies explored various compounds as potential culprits for the pain, but none fully replicated the intensity and duration of the sting. wikipedia.org this compound was identified around 1970 and initially considered a primary causative agent, although later research indicated that while it contributes to pain, it may not be solely responsible, suggesting the presence of other toxins. wikipedia.orgwikipedia.org More recently, other peptide families like gympietides have also been identified in D. moroides. wikipedia.org
Research into this compound's anti-mitotic activity, specifically its effect on tubulin, gained prominence as the understanding of its molecular target developed. wikipedia.orgjst.go.jp The challenging nature of isolating sufficient quantities of this compound from its natural sources and the complexities of its chemical synthesis have historically limited extensive research and drug development efforts. google.comumich.edu This challenge has spurred academic research into the biosynthetic pathways of this compound and related plant cyclopeptides. Recent studies have focused on elucidating the enzymatic machinery involved in this compound biosynthesis, particularly the role of BURP-domain peptide cyclases, and exploring the feasibility of producing this compound and its analogs through ribosomal synthesis and post-translational modification in heterologous plant systems like tobacco. google.comacs.orgnih.govumich.edumit.edu This biosynthetic approach represents a significant advancement in overcoming the supply limitations that have historically impacted research on this compound-type peptides. google.comacs.orgnih.gov The study of this compound also fits within the broader context of research into ribosomally synthesized and posttranslationally modified peptides (RiPPs) in plants, a class of compounds increasingly recognized for their diverse structures and bioactivities. acs.orgnih.govumich.eduresearchgate.net
Properties
Molecular Formula |
C47H66N14O10 |
---|---|
Molecular Weight |
987.1 g/mol |
IUPAC Name |
(8R,9S,12S,15S,18S,21S,27S)-21-[3-(diaminomethylideneamino)propyl]-12-(2-methylpropyl)-10,13,16,19,22,25-hexaoxo-9-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-8,15-di(propan-2-yl)-2,11,14,17,20,23,26,30,32-nonazapentacyclo[16.14.2.13,7.129,32.04,33]hexatriaconta-1(33),3,5,7(36),29(35),30-hexaene-27-carboxylic acid |
InChI |
InChI=1S/C47H66N14O10/c1-21(2)14-31-43(67)59-37(23(5)6)44(68)58-32-17-27-26-10-9-24(36(22(3)4)38(45(69)57-31)60-41(65)29-11-12-34(62)53-29)15-30(26)55-39(27)61-19-25(52-20-61)16-33(46(70)71)54-35(63)18-51-40(64)28(56-42(32)66)8-7-13-50-47(48)49/h9-10,15,19-23,28-29,31-33,36-38,55H,7-8,11-14,16-18H2,1-6H3,(H,51,64)(H,53,62)(H,54,63)(H,56,66)(H,57,69)(H,58,68)(H,59,67)(H,60,65)(H,70,71)(H4,48,49,50)/t28-,29-,31-,32-,33-,36+,37-,38-/m0/s1 |
InChI Key |
UCSHFBQCLZMAJY-QFMFBHDYSA-N |
SMILES |
CC(C)CC1C(=O)NC(C(=O)NC2CC3=C(NC4=C3C=CC(=C4)C(C(C(=O)N1)NC(=O)C5CCC(=O)N5)C(C)C)N6C=C(CC(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)C(=O)O)N=C6)C(C)C |
Isomeric SMILES |
CC(C)C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CC3=C(NC4=C3C=CC(=C4)[C@H]([C@@H](C(=O)N1)NC(=O)[C@@H]5CCC(=O)N5)C(C)C)N6C=C(C[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)CCCN=C(N)N)C(=O)O)N=C6)C(C)C |
Canonical SMILES |
CC(C)CC1C(=O)NC(C(=O)NC2CC3=C(NC4=C3C=CC(=C4)C(C(C(=O)N1)NC(=O)C5CCC(=O)N5)C(C)C)N6C=C(CC(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)C(=O)O)N=C6)C(C)C |
Origin of Product |
United States |
Total Synthesis and Advanced Synthetic Studies of Moroidin and Analogues
Overcoming Complexities in Chemical Synthesis of Moroidin
The total synthesis of this compound presents considerable challenges primarily due to its intricate bicyclic peptide structure and the presence of unusual amino acid cross-links. google.comacs.org Specifically, the formation of the C-C bond between leucine and tryptophan and the C-N bond between tryptophan and histidine requires highly selective and efficient synthetic methodologies. google.comacs.orgwikipedia.org Low isolation yields from natural sources further underscore the need for effective synthetic routes for research and potential therapeutic development. google.comacs.orgnih.gov While the total synthesis of this compound itself had not been fully described in some reports, significant progress has been made on the synthesis of its structural analogue, celogentin C, which shares the key cross-linkages. google.comwikipedia.org
Strategic Approaches for Constructing Bicyclic Peptide Scaffolds
Constructing the bicyclic peptide scaffold of this compound involves forming two macrocyclic rings through side-chain cross-linkages. google.comwikipedia.org This typically requires strategic peptide coupling reactions and selective bond formations at the desired amino acid residues. Approaches to synthesizing similar bicyclic peptides often involve building the linear peptide chain first, followed by sequential or simultaneous macrocyclization steps. The specific challenges in this compound synthesis lie in the non-standard C-C and C-N linkages involving the indole and imidazole rings. google.comacs.orgwikipedia.org
Partial Syntheses and Targeted Investigations of Specific Cross-Linkages
Due to the complexity of the full structure, research has often focused on the partial synthesis of this compound, specifically targeting the formation of the key cross-linkages. Partial syntheses including the Leu-Trp and Trp-His linkages have been achieved. wikipedia.org
Specific approaches for the Leu-Trp cross-link have included methods involving intermolecular Knoevenagel condensation followed by radical conjugate addition and nitro reduction, although this can yield diastereomeric mixtures. wikipedia.org Another strategy for the Leu-Trp crosslink involves a palladium-catalyzed C-H functionalization reaction to stereoselectively form the bond. google.com
For the Trp-His cross-link (C2 of tryptophan indole to N1 of histidine imidazole), oxidative coupling methods, such as using N-chlorosuccinimide (NCS), have been employed. wikipedia.org Careful control of reaction conditions is necessary to prevent over-oxidation or side reactions. wikipedia.org These partial syntheses have been crucial in developing the methodologies required for assembling the full bicyclic system.
Development of Biomimetic and Chemoenzymatic Synthetic Routes
Recognizing the challenges of purely organic synthesis and the low natural abundance, researchers have explored alternative approaches, including biomimetic and chemoenzymatic routes. mdpi.com Studies into the biosynthesis of this compound in plants like Dendrocnide moroides and Celosia argentea have revealed that these peptides are ribosomally synthesized and post-translationally modified (RiPPs). google.commit.eduacs.org A key enzyme in this process is a copper-dependent BURP-domain peptide cyclase, such as KjaBURP from Kerria japonica, which catalyzes the formation of the tryptophan-indole-centered macrocyclic bonds. mit.eduacs.orgumich.edu
This understanding of the biosynthetic pathway has paved the way for chemoenzymatic strategies. One notable development is the in planta biosynthesis of this compound and its analogues by expressing the relevant precursor genes, such as the predicted precursor gene from K. japonica, in heterologous plant systems like tobacco. mdpi.com This approach leverages the plant's own machinery, guided by the introduced gene, to perform the complex enzymatic cyclization and modifications, allowing for the production of this compound and diverse analogues on a milligram scale without extensive traditional organic synthesis. mdpi.com While in vitro reconstitution of the biosynthesis using the BURP domain has also been explored, challenges remain in optimizing the speed and yield of the enzymatic cyclization for large-scale production.
Synthetic Modulations for Analog Generation
Synthetic studies are not limited to the total synthesis of the parent compound but also extend to the generation of this compound analogues. This is important for exploring structure-activity relationships and developing potential therapeutics. mit.edu Both traditional organic synthesis and biosynthetic approaches offer avenues for creating analogues.
In organic synthesis, modifications can be introduced by using modified amino acid building blocks or by altering the cyclization strategies to form different ring sizes or incorporate different residues.
Using the insights from biosynthesis, analogue generation can be achieved by modifying the core peptide sequences within the precursor genes expressed in host plants. mit.edu By varying the amino acid sequence that corresponds to the this compound peptide motif in the precursor protein, researchers have demonstrated the feasibility of producing diverse this compound-like peptides. mit.eduacs.org This gene-guided approach allows for the exploration of a library of this compound-based peptides, facilitating the discovery of analogues with potentially improved properties. acs.org
Molecular and Cellular Mechanisms of Moroidin's Action
Anti-mitotic Activity and Microtubule Dynamics Modulation
Moroidin's anti-mitotic activity stems from its ability to modulate the dynamic behavior of microtubules. wikipedia.orgresearchgate.net Microtubules, composed of α- and β-tubulin heterodimers, are essential components of the cytoskeleton and play vital roles in maintaining cell structure, intracellular transport, and chromosome segregation during mitosis. researchgate.net Agents that disrupt microtubule dynamics interfere with the formation and proper function of the mitotic spindle, leading to impaired chromosome segregation and ultimately cell death. researchgate.net
Inhibition of Tubulin Polymerization
A key mechanism by which this compound affects microtubule dynamics is the inhibition of tubulin polymerization. wikipedia.orggoogle.com Tubulin heterodimers assemble to form protofilaments, which then associate to form hollow cylindrical microtubules. researchgate.net this compound has been shown to strongly inhibit this polymerization process. researchgate.net Studies have indicated that this compound has a potent inhibitory effect on purified tubulin polymerization. researchgate.netacs.org For instance, the inhibitory IC50 value of this compound on tubulin polymerization has been reported as 3.0 μM. researchgate.netresearchgate.net This inhibition prevents the formation of the dynamic microtubule structures necessary for cellular processes, especially during mitosis.
Disruption of Cellular Microtubule Networks
Beyond inhibiting polymerization, this compound also disrupts existing cellular microtubule networks. Cellular evidence has shown that this compound disrupts microtubule polymerization and can decrease β-tubulin protein levels. researchgate.netacs.org Immunofluorescence studies in A549 cells treated with this compound have revealed a dose-dependent reduction and fragmentation of the microtubule network, accompanied by alterations in cell morphology. This disruption compromises the structural integrity of the cell and impairs processes dependent on intact microtubule networks.
Characterization of Tubulin Binding Sites (e.g., Vinca Alkaloid Site Interactions)
This compound exerts its effects by binding to tubulin. Molecular docking studies have indicated that this compound has a high binding potential to the vinca alkaloid site on tubulin. researchgate.netresearchgate.netacs.org The vinca alkaloid binding site is distinct from other binding sites on tubulin, such as those for taxanes, colchicine, podophyllotoxin, and GTP. nih.govuah.es Binding of vinca alkaloids to their sites, typically located at the ends of microtubules, disrupts microtubule assembly and suppresses microtubule dynamics. nih.gov While this compound's interaction with the vinca alkaloid site is suggested by docking studies, further detailed characterization of its specific binding mode and affinity relative to established vinca alkaloids would provide a more comprehensive understanding of this interaction.
Regulation of Cell Cycle Progression
The disruption of microtubule dynamics by this compound has direct consequences for cell cycle progression, particularly during mitosis. researchgate.net
Induction of G2/M Phase Arrest
This compound has been shown to induce cell cycle arrest, specifically in the G2/M phase. researchgate.netresearchgate.netacs.org This arrest occurs because the disruption of the mitotic spindle by this compound activates the mitotic checkpoint, which prevents cells from progressing into anaphase and completing cell division. wikipedia.org Studies in A549 cells have demonstrated that this compound treatment causes a dose-dependent increase in the proportion of cells in the G2/M phase, with a corresponding decrease in the G1 phase population. This accumulation of cells in the G2/M phase is a hallmark of anti-mitotic agents that interfere with microtubule function.
Table 1: Effect of this compound on Cell Cycle Distribution in A549 Cells
This compound Concentration | G1 Phase (%) | S Phase (%) | G2/M Phase (%) |
Control | Data not available in snippets | Data not available in snippets | Data not available in snippets |
0-20 μM | Decreased | Data not available in snippets | Increased |
Note: Specific percentage data for control and various concentrations across all phases were not consistently available across the provided snippets, but the trend of decreased G1 and increased G2/M is reported.
Downstream Cellular Events of Cell Cycle Inhibition
The cell cycle arrest induced by this compound can lead to downstream cellular events, including the induction of apoptosis. researchgate.netacs.org Apoptosis, or programmed cell death, is a crucial mechanism for eliminating damaged or abnormal cells. This compound has been shown to induce apoptosis in cancer cells, such as A549 human lung cancer cells. researchgate.netacs.org The intrinsic mitochondrial pathway and the AKT signaling pathway have been reported to be involved in this compound-induced cell apoptosis. researchgate.netacs.org The disruption of mitosis and subsequent cell cycle arrest trigger signaling cascades that can activate apoptotic pathways, leading to the demise of affected cells. researchgate.netmdpi.com
Mechanisms of Apoptotic Induction
This compound has been shown to induce apoptosis in cancer cells through various pathways and molecular interactions. researchgate.netacs.orgnih.govchemsrc.com
Activation of the Intrinsic Mitochondrial Apoptosis Pathway
Studies have indicated that this compound activates the intrinsic mitochondrial apoptosis pathway in cancer cells, such as A549 human lung cancer cells. researchgate.netacs.orgnih.govchemsrc.com This pathway is a major route for initiating apoptosis in response to various intracellular stresses. abcam.cn Activation of this pathway by this compound involves the release of cytochrome C from the mitochondria into the cytosol. researchgate.net The release of cytochrome C is a key event that triggers the formation of the apoptosome, a protein complex essential for downstream caspase activation. wikipedia.orgrndsystems.com
Caspase Cascade Activation (e.g., Caspase-3, Caspase-9)
A critical step in this compound-induced apoptosis is the activation of the caspase cascade. researchgate.net Caspases are a family of proteases that are central mediators of apoptosis. wikipedia.orgrndsystems.com this compound has been shown to activate both initiator caspases, such as caspase-9, and executioner caspases, such as caspase-3, in cancer cells. researchgate.netmedsci.org Caspase-9 is activated within the apoptosome, which is formed following the release of cytochrome C from the mitochondria in the intrinsic pathway. wikipedia.orgrndsystems.com Activated caspase-9, in turn, cleaves and activates executioner caspases like caspase-3. wikipedia.orgrndsystems.comembopress.org Activated caspase-3 is responsible for cleaving numerous cellular substrates, leading to the morphological and biochemical hallmarks of apoptosis. wikipedia.orgrndsystems.comembopress.org
Modulation of Bcl-2 Family Protein Expression (e.g., Bax Upregulation, Bcl-2 Downregulation)
The Bcl-2 protein family plays a crucial role in regulating the intrinsic apoptotic pathway by controlling mitochondrial outer membrane permeabilization (MOMP). wikipedia.orgnih.govnih.govresearchgate.net This family includes both anti-apoptotic members (e.g., Bcl-2, Bcl-xL) that inhibit apoptosis and pro-apoptotic members (e.g., Bax, Bak, BH3-only proteins) that promote it. wikipedia.orgnih.govnih.govresearchgate.netthno.org this compound has been observed to modulate the expression of these proteins, specifically causing the upregulation of the pro-apoptotic protein Bax and the downregulation of the anti-apoptotic protein Bcl-2 in cancer cells. researchgate.netmedsci.orgnih.gov The balance between pro- and anti-apoptotic Bcl-2 family proteins determines a cell's susceptibility to apoptosis. rndsystems.comwikipedia.orgnih.govresearchgate.net An increased Bax/Bcl-2 ratio favors MOMP and the release of pro-apoptotic factors like cytochrome C, thereby promoting apoptosis. researchgate.netmedsci.orgnih.gov
Research findings on the effect of this compound on Bcl-2 family protein expression:
Protein | Effect of this compound Treatment | Observed in Cell Line | Reference |
Bax | Upregulation | A549 human lung cancer cells | researchgate.net |
Bcl-2 | Downregulation | A549 human lung cancer cells | researchgate.net |
Bax/Bcl-2 Ratio | Increased | Fetal rat brain (in response to prenatal cocaine exposure, relevant mechanism) | medsci.org |
Poly (ADP-ribose) Polymerase (PARP) Cleavage
Cleavage of Poly (ADP-ribose) Polymerase (PARP) is a well-established marker of apoptosis and is typically carried out by activated executioner caspases, particularly caspase-3. embopress.orgbiolegend.comabcam.comthermofisher.com PARP is a nuclear protein involved in DNA repair, and its cleavage inactivates its repair function, contributing to the controlled dismantling of the cell during apoptosis. biolegend.comabcam.comthermofisher.commdpi.com Studies on this compound have shown that it induces PARP cleavage in cancer cells, indicating the activation of the downstream apoptotic machinery. researchgate.net
Involvement of Key Signaling Pathways in Apoptosis (e.g., AKT Pathway)
Signaling pathways play a crucial role in regulating cell survival and death. The AKT pathway, also known as the PI3K/AKT pathway, is often involved in promoting cell survival and inhibiting apoptosis. nih.govoncotarget.com Research suggests that the AKT pathway is involved in this compound-induced cell apoptosis. researchgate.netacs.orgnih.govresearchgate.net While the precise mechanism of AKT involvement in this compound-induced apoptosis requires further detailed investigation, its implication suggests that this compound may counteract pro-survival signals mediated by this pathway, thereby promoting cell death.
Anti-migratory and Anti-invasive Effects on Cancer Cells
Beyond its apoptotic effects, this compound has also demonstrated the ability to inhibit the migration and invasion of cancer cells, particularly in glioblastoma (GBM) cells and A549 lung cancer cells. researchgate.netacs.orgnih.govresearchgate.netnih.govfigshare.comjbr-pub.org.cn Cell migration and invasion are critical processes in cancer progression and metastasis. oncotarget.com
Studies have shown that this compound significantly suppressed cell migration and invasion in A549 cells at sublethal concentrations. researchgate.netacs.orgnih.govfigshare.com In glioblastoma cells, this compound inhibited cell migration and tube formation, which is a measure of vasculogenic mimicry (VM), an alternative mechanism of blood supply in aggressive tumors. researchgate.netnih.govjbr-pub.org.cn
The anti-migratory and anti-invasive effects of this compound in glioblastoma cells have been linked to the regulation of the epithelial-mesenchymal transition (EMT) pathway and β-catenin activation. researchgate.netnih.govjbr-pub.org.cn EMT is a process by which cancer cells acquire migratory and invasive properties. researchgate.netnih.gov this compound treatment led to a concentration-dependent decrease in the expression of EMT markers such as N-cadherin and vimentin in GBM cells. researchgate.netnih.gov Furthermore, this compound significantly reduced the level of phosphorylated extracellular signal-regulated protein kinase (p-ERK) and inhibited the activation of β-catenin. researchgate.netnih.gov These findings suggest that this compound inhibits VM formation in GBM cells by regulating the ERK/β-catenin-mediated EMT pathway. researchgate.netnih.govjbr-pub.org.cn
Research findings on the anti-migratory and anti-invasive effects of this compound:
Effect | Cell Line | Key Mechanism Involved | Reference |
Inhibited Migration | A549 lung cancer cells | Not explicitly detailed in snippets, but observed effect | researchgate.netacs.orgnih.govfigshare.com |
Inhibited Invasion | A549 lung cancer cells | Not explicitly detailed in snippets, but observed effect | researchgate.netacs.orgnih.govfigshare.com |
Suppressed Migration | Glioblastoma (U87, U251) | Regulation of ERK/β-catenin-mediated EMT pathway | researchgate.netnih.govjbr-pub.org.cn |
Inhibited Tube Formation (VM) | Glioblastoma (U87, U251) | Regulation of ERK/β-catenin-mediated EMT pathway | researchgate.netnih.govjbr-pub.org.cn |
Inhibition of Cancer Cell Migration in in vitro Models
Studies have demonstrated that this compound can significantly suppress the migration of cancer cells in vitro. For instance, this compound has been shown to reduce the migration of A549 human lung cancer cells at sublethal concentrations. researchgate.netchemsrc.comacs.orgnih.gov In glioblastoma cell lines, such as U87 and U251, this compound also significantly suppressed cell migration. nih.govresearchgate.netjbr-pub.org.cnjbr-pub.org.cn Experimental assays like the wound scratch assay and Transwell migration assay are commonly used to evaluate this inhibitory effect. In the wound scratch assay, the distance covered by cells migrating into a scratched area is quantified after treatment with this compound, showing a dose-dependent inhibition. chemsrc.com Similarly, Transwell migration assays measure the number of cells that migrate through a porous membrane, with this compound treatment leading to a significant reduction in migrated cells. chemsrc.com
Table 1: Effect of this compound on Cancer Cell Migration (Illustrative Data based on findings)
Cell Line | This compound Concentration (µM) | Relative Migration (%) | Reference |
A549 | 0.5 | Reduced | chemsrc.com |
A549 | 1 | Further Reduced | chemsrc.com |
A549 | 2 | Significantly Reduced | chemsrc.com |
U87 | 0.5 | Suppressed | nih.govjbr-pub.org.cn |
U87 | 1 | Suppressed | nih.govjbr-pub.org.cn |
U87 | 2 | Significantly Suppressed | nih.govjbr-pub.org.cn |
U251 | 0.5 | Suppressed | nih.govjbr-pub.org.cn |
U251 | 1 | Suppressed | nih.govjbr-pub.org.cn |
U251 | 2 | Significantly Suppressed | nih.govjbr-pub.org.cn |
Note: Relative Migration (%) is a conceptual representation based on reported inhibitory effects at given concentrations.
Suppression of Cancer Cell Invasion Capabilities
In addition to inhibiting migration, this compound has also been shown to suppress the invasion capabilities of cancer cells. chemsrc.comacs.orgnih.gov Cancer cell invasion, the process by which cancer cells move through the extracellular matrix, is a critical step in metastasis. Studies using in vitro invasion assays, such as those utilizing Matrigel-coated Transwell chambers, have demonstrated that this compound treatment leads to a decrease in the number of invasive cancer cells. chemsrc.com For A549 lung cancer cells, this compound decreased the invasion number in a dose-dependent manner. chemsrc.com This suppression of invasion contributes to this compound's potential anti-cancer effects by limiting the spread of tumor cells.
Table 2: Effect of this compound on Cancer Cell Invasion (Illustrative Data based on findings)
Cell Line | This compound Concentration (µM) | Relative Invasion (%) | Reference |
A549 | 0.5 | Decreased | chemsrc.com |
A549 | 1 | Further Decreased | chemsrc.com |
A549 | 2 | Significantly Decreased | chemsrc.com |
Note: Relative Invasion (%) is a conceptual representation based on reported inhibitory effects at given concentrations.
Anti-Vasculogenic Mimicry (VM) Activity
Vasculogenic mimicry (VM) is a process employed by aggressive tumor cells, particularly under conditions of hypoxia and nutrient deficiency, to form fluid-conducting channels that supplement or replace endothelial cell-lined vessels, thereby contributing to tumor blood supply and resistance to anti-angiogenic therapies. nih.govjbr-pub.org.cntandfonline.com this compound has been identified as a potential agent against VM, particularly in glioblastoma (GBM). nih.govresearchgate.netjbr-pub.org.cn
Inhibition of VM Formation in Glioblastoma (GBM) Cells
This compound has been shown to significantly inhibit VM formation in GBM cells in vitro at non-cytotoxic concentrations. nih.govjbr-pub.org.cnjbr-pub.org.cn In vitro Matrigel tube formation assays are commonly used to assess VM. nih.govjbr-pub.org.cn In these assays, aggressive cancer cells are cultured on a Matrigel matrix, and their ability to form tube-like structures is observed and quantified. nih.govjbr-pub.org.cn Treatment with this compound significantly inhibited the formation of vasculogenic-like networks by GBM cell lines such as U87 and U251, reducing the numbers of meshes and master segments formed. nih.govjbr-pub.org.cn For instance, in U87 cells treated with 0.5, 1, and 2 μmol/L this compound, the numbers of meshes were reduced to 55.26%, 43.82%, and 34.51%, respectively, compared to the vehicle control group. nih.gov Master segments were similarly reduced to 64.49%, 57.07%, and 54.01% at these concentrations. nih.gov
Table 3: Effect of this compound on VM Formation in U87 GBM Cells nih.gov
This compound Concentration (µmol/L) | Relative Number of Meshes (%) | Relative Number of Master Segments (%) |
0 | 100 | 100 |
0.5 | 55.26 | 64.49 |
1 | 43.82 | 57.07 |
2 | 34.51 | 54.01 |
Regulation of the Epithelial-Mesenchymal Transition (EMT) Pathway
A key mechanism underlying this compound's anti-VM effect is its regulation of the epithelial-mesenchymal transition (EMT) pathway. nih.govresearchgate.netjbr-pub.org.cnjbr-pub.org.cntandfonline.comresearchgate.netjensenlab.org EMT is a biological process where epithelial cells acquire mesenchymal characteristics, which is crucial for tumor invasion, VM formation, and drug resistance. nih.govresearchgate.net RNA sequencing data have suggested the involvement of the EMT pathway in the mechanism of this compound. researchgate.netnih.govresearchgate.netjbr-pub.org.cnresearchgate.netjensenlab.org this compound treatment leads to the inhibition of EMT in GBM cells. nih.gov This is evidenced by changes in the expression levels of key EMT markers. researchgate.netnih.govresearchgate.netjbr-pub.org.cnresearchgate.net222.198.130jbr-pub.org.cn
Modulation of Associated Signaling Molecules (e.g., ERK, β-catenin, N-cadherin, vimentin)
This compound modulates several signaling molecules associated with EMT and VM. Exposure to this compound leads to a concentration-dependent decrease in the expression levels of mesenchymal state markers, including N-cadherin and vimentin, in GBM cells. researchgate.netnih.govresearchgate.netjbr-pub.org.cnresearchgate.net222.198.130jbr-pub.org.cn Conversely, the expression level of the epithelial marker E-cadherin is increased after this compound treatment. nih.gov
Furthermore, this compound significantly reduces the level of phosphorylated extracellular signal-regulated protein kinase (p-ERK) and inhibits the activation of β-catenin. researchgate.netnih.govresearchgate.netjbr-pub.org.cnjensenlab.org222.198.130 The ERK/β-catenin pathway plays a significant role in regulating EMT and VM in GBM cells. nih.govresearchgate.netjbr-pub.org.cntandfonline.com this compound inhibits VM formation by suppressing the ERK/β-catenin-mediated EMT. nih.govresearchgate.netjbr-pub.org.cnjbr-pub.org.cn While this compound inhibits β-catenin activation and nuclear translocation, it does not suppress the total expression level of β-catenin. nih.gov The inhibition of β-catenin activation by this compound suppresses the EMT process in GBM cells, ultimately impairing VM formation. nih.govresearchgate.netresearchgate.net The this compound-induced decrease in active β-catenin, N-cadherin, vimentin, and matrix metalloproteinase-9 (MMP-9) can be rescued by the β-catenin agonist SKL2001, further validating the role of the β-catenin/EMT pathway in this compound's anti-VM effects. nih.govresearchgate.netresearchgate.net
Table 4: Modulation of EMT-Related Proteins by this compound in GBM Cells (Conceptual representation based on findings)
Protein | Effect of this compound Treatment | Reference |
N-cadherin | Decreased expression | researchgate.netnih.govresearchgate.netjbr-pub.org.cnresearchgate.net222.198.130jbr-pub.org.cn |
Vimentin | Decreased expression | researchgate.netnih.govresearchgate.netjbr-pub.org.cnresearchgate.net222.198.130jbr-pub.org.cn |
E-cadherin | Increased expression | nih.gov |
p-ERK | Reduced level | researchgate.netnih.govresearchgate.netjbr-pub.org.cnjensenlab.org222.198.130 |
Active β-catenin | Inhibited activation/decrease | researchgate.netnih.govresearchgate.netjbr-pub.org.cn222.198.130researchgate.netresearchgate.net |
Total β-catenin | Not suppressed | nih.gov |
SNAIL | Decreased expression | nih.gov |
TWIST | Decreased expression | nih.gov |
MMP-9 | Decreased expression | nih.govresearchgate.netjbr-pub.org.cnresearchgate.netresearchgate.net |
The pharmacological mechanisms of this compound against VM formation in GBM cells involve the regulation of the ERK/β-catenin-dependent EMT pathway, leading to suppressed cell motility, migration, and subsequent VM formation at sublethal concentrations. nih.govjbr-pub.org.cnresearchgate.net
Structure-activity Relationships Sar of Moroidin and Its Analogues
Correlating Bicyclic Ring System Architecture with Biological Activity
The bicyclic ring system is a defining feature of moroidin and the celogentins, formed by unusual non-peptide cross-connections. Research indicates that this intricate bicyclic architecture is crucial for their biological activity, specifically their interaction with tubulin. The presence of the bicyclic system, including these unique linkages, appears to be a fundamental requirement for the observed anti-mitotic effects. Studies comparing bicyclic this compound-type peptides to monocyclic analogues, such as stephanotic acid-[LV], suggest that the second ring is required for cytotoxicity against certain cancer cell lines.
Significance of Unusual Leu-Trp and Trp-His Cross-Linkages in Bioactivity
This compound's structure includes two distinctive cross-links: a carbon-carbon (C-C) bond between the β-carbon of a leucine residue and the C6 of a tryptophan indole, and a carbon-nitrogen (C-N) bond connecting the C2 of the same tryptophan indole to the N1 of a C-terminal histidine imidazole. nih.govresearchgate.net These cross-linkages are integral to the formation of the bicyclic scaffold. nih.govresearchgate.net The Trp-His cross-link, in particular, forms the second ring of the bicyclic system, and its presence is necessary for the bioactivity of this compound-type peptides. The specific structure of the right-hand ring, which contains the Trp-His linkage, has been correlated with the degree of biological activity. nih.gov
Influence of Ring Size and Conformation on Target Interaction and Efficacy
The size and conformation of the bicyclic rings play a significant role in the interaction of this compound and its analogues with their biological target, tubulin. Cyclization in peptides generally leads to reduced conformational flexibility, which can enhance metabolic stability and improve binding affinity and specificity to target molecules. Bicyclic peptides, with their further constrained structures, exhibit even greater conformational rigidity compared to their linear or monocyclic counterparts. The second ring in moroidins can vary in size, typically comprising 2 to 4 amino acids. Variations in ring size and the resulting conformations are considered important factors influencing their biological activity. Synthetic efforts have explored altering the size of the right-hand ring to investigate the impact on activity.
Comparative Structure-Activity Profiles of Celogentins and other this compound-Type Analogues
The celogentins, a family of bicyclic peptides isolated from Celosia argentea, are structurally related to this compound and share its anti-mitotic activity through tubulin polymerization inhibition. Comparative studies have revealed distinct differences in potency among these compounds. Celogentin C is consistently reported as being significantly more potent in inhibiting tubulin polymerization than this compound. nih.gov While this compound demonstrates an inhibitory activity with an IC₅₀ of 3.0 µM, comparable to that of vinblastine, celogentin C exhibits a higher potency with an IC₅₀ of 0.8 µM. nih.gov This difference in potency has been linked to variations in the structure of the right-hand ring. nih.gov Specifically, celogentin C contains a proline residue in its right-hand ring, whereas this compound has a glycine residue in the corresponding position, leading to presumably different conformations of this macrocycle. Other celogentins, such as celogentins A, B, and D, have shown significantly lower activity compared to this compound and celogentin C. The presence of an additional lysine residue in celogentin B did not appear to substantially affect its inhibitory activity. Furthermore, the discovery of this compound analogues from other plant sources, such as a water chickweed analogue showing higher cytotoxicity against lung adenocarcinoma cells than this compound, highlights the potential for structural variations to influence biological activity.
Compound | IC₅₀ (µM) for Tubulin Polymerization Inhibition | Notes |
This compound | 3.0 | Comparable to Vinblastine |
Celogentin C | 0.8 | More potent than this compound and Vinblastine |
Vinblastine | 3.0 | Reference anti-mitotic agent |
Celogentins A, B, D | 20-30 | Significantly less active than this compound and Celogentin C |
Table 1: Comparative Potency of this compound, Celogentin C, and Vinblastine in Tubulin Polymerization Inhibition nih.gov
Q & A
Q. What are the primary molecular mechanisms through which Moroidin exerts its anti-cancer effects in glioblastoma models?
this compound inhibits glioblastoma (GBM) progression via dual mechanisms: (1) microtubule disruption by binding to tubulin, preventing polymerization (observed in celogentin C analogs) , and (2) suppression of epithelial-mesenchymal transition (EMT) by downregulating N-cadherin, vimentin, and β-catenin signaling. RNA sequencing and GSEA analysis revealed significant downregulation of EMT-related genes (e.g., MMP9, MMP14) and inhibition of ERK/β-catenin pathways in U87/U251 cells treated with 2 µM this compound . Western blot and immunofluorescence validated dose-dependent reduction in phosphorylated ERK and nuclear β-catenin .
Q. Which experimental assays are commonly employed to evaluate this compound's inhibitory effects on glioblastoma cell migration and vasculogenic mimicry (VM)?
Key assays include:
- Wound scratch assay : Cells cultured to 80% confluency are scratched and treated with this compound (0.5–2 µM). Migration distance is quantified via ImageJ after 24 hours .
- Transwell migration : Cells in this compound-treated upper chambers are fixed, stained, and counted after 24 hours .
- Matrigel tube formation : VM inhibition is assessed by counting tubular networks in GBM cells seeded on Matrigel. This compound (2 µM) reduces network complexity by 55% (U87) and 34% (U251) .
- qRT-PCR/Western blot : Validates downregulation of EMT markers (e.g., MMP9, vimentin) using primers/probes listed in Table 1 of .
Advanced Research Questions
Q. How can researchers reconcile contradictory findings regarding this compound's role in pain induction versus its anti-cancer properties?
While this compound was initially linked to neuropathic pain in Dendrocnide moroides, recent studies suggest its isolated form induces less pain than crude plant extracts . This discrepancy may arise from synergistic interactions with other plant toxins (e.g., histamines) or differences in in vivo vs. in vitro models. To resolve this, comparative metabolomics of plant extracts and purified this compound, paired with in vivo nociception assays (e.g., mouse paw-licking tests), are recommended .
Q. What methodologies are recommended for optimizing heterologous production of this compound analogs in non-native plant systems?
The Weng group’s gene-guided approach includes:
- BURP domain mining : Screening 793 plant transcriptomes for this compound-like motifs to identify functional cyclization enzymes .
- Copper-dependent catalysis : Utilizing copper ions to enable cyclization of tryptophan-indole macrocycles in engineered tobacco .
- Diversification : Modifying core peptide sequences in Nicotiana benthamiana to produce analogs like celogentin C, which showed selective cytotoxicity in H1437 lung adenocarcinoma cells (IC50: 1.2 µM) .
Q. How can researchers integrate multi-omics data to elucidate this compound's dual role in microtubule targeting and EMT inhibition?
A proposed workflow:
Transcriptomics : RNA-seq of this compound-treated GBM cells to identify EMT pathway suppression .
Network analysis : STRING database integration to map protein-protein interactions between EMT markers (e.g., MMP9, β-catenin) and microtubule regulators .
Functional validation : CRISPR knockdown of β-catenin in GBM cells to test if this compound’s anti-migratory effects persist .
Methodological Considerations for Data Contradiction
Q. What statistical approaches are critical for analyzing dose-dependent effects of this compound in migration assays?
Q. How should researchers address variability in this compound's bioactivity across different glioblastoma cell lines?
- Line-specific profiling : Compare baseline expression of β-catenin and EMT markers (e.g., U87 has higher vimentin than U251) .
- Normalization to housekeeping genes : Use GAPDH or β-actin for qRT-PCR/Western blot to control for loading differences .
Emerging Research Directions
Q. Can this compound analogs be engineered to enhance blood-brain barrier (BBB) penetration for glioblastoma therapy?
Q. What in vivo models are suitable for validating this compound's anti-VM efficacy?
- Orthotopic GBM xenografts : Intracranial implantation of luciferase-tagged U87 cells in nude mice, with this compound administered via osmotic pump (2 mg/kg/day) .
- Dynamic contrast-enhanced MRI : Monitor VM reduction by tracking gadolinium leakage in tumors .
Retrosynthesis Analysis
AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.
One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.
Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.
Strategy Settings
Precursor scoring | Relevance Heuristic |
---|---|
Min. plausibility | 0.01 |
Model | Template_relevance |
Template Set | Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis |
Top-N result to add to graph | 6 |
Feasible Synthetic Routes
Featured Recommendations
Most viewed | ||
---|---|---|
Most popular with customers |
Disclaimer and Information on In-Vitro Research Products
Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.